BETH PSAILA, M.D., PHD
Associate Professor of Haematology, Univ. of Oxford
CRUK Advanced Clinical Scientist
Haematology Consultant, Churchill Hospital
Senior Fellow, New College Oxford
Beth is a Group Leader at the MRC Weatherall Institute of Molecular Medicine and a haematology consultant specialising in the care of patients with myeloproliferative neoplasms. Before Oxford, she trained at Clare College, Cambridge University, University College London Hospitals and The Hammersmith Hospital/Imperial College London and also spent >6 years in the US at Cornell University, New York and the National Human Genome Research Institute, National Institutes of Health, Bethesda. She has been studying megakaryocytes/platelets and haematopoiesis for >15 years, leading to a strong national and international research network. She is passionate about translational science, motivated to apply state-of-the-art techniques to better understand mechanisms of disease in her patients, identify new therapeutic strategies and develop more clinically relevant models for target validation.
Beth is highly committed to training and mentoring. Alumni from her group have an excellent track record in securing personal fellowships, independent grant funding and positions in industry. Together with Adam Mead, she is a co-founder of Alethiomics, a recent spin-out company from the WIMM.
Outside of work, she enjoys adventures with her husband and three children, and escaping for runs around beautiful Oxford with her over-enthusiastic but surprisingly obedient cockapoo.
ABDULLAH KHAN, PHD
Sir Henry Wellcome Postdoctoral Fellow
Institute of Cardiovascular Sciences, Birmingham
& Psaila Lab, MRC WIMM Oxford
Abs Khan is a Henry Wellcome Fellow.
His background is in CRISPR gene editing and super-resolution microscopy. His fellowship has been focused on developing physiologically relevant, 3D models using induced pluripotent stem cells (iPSCs). He led our recent work published in Cancer Discovery developing and validating an iPSC-derived bone marrow organoids platform for disease modelling, target discovery and validation.
CAMELIA BENLABIOD, PHD
Camelia recently joined us from Gustave Roussy, Paris where she completed her PhD with Caroline Marty and Isabel Plo studying the mechanisms of action and phenotypic differences between the two common types of mutations in calreticulin in Myeloproliferative Neoplasms. We are thrilled that she has joined our group, and she will be working on developing new models of myeloproliferative neoplasms.
RONG LI, PHD
Chinese Academy of Medical Sciences Senior Postdoctoral Fellow, Psaila Lab
Rong is using single cell approaches to study mechanisms of inflammation and fibrosis in myelofibrosis using primary patient cells and in vivo/in vitro systems. She was awarded a prestigious Chinese Academy of Medical Sciences Fellowship to focus on immune cells in MPNs, working in collaboration between the Psaila lab and that of Professor Tao Dong, Human Immunology Unit, MRC WIMM.
NATALIE JOOSS, PHD
Natalie recently joined us after completing a dual PhD in Maastricht and Birmingham. We are delighted that she has joined us, bringing her extensive skills in platelet biology and platelet function.
Lauren worked for 2 years in industry before joining the Psaila lab as a research assistant funded by CRUK and the Emerson Collective.
She secured a CRUK-funded DPhil studentship and is in her 3rd year, working on an exciting project exploring the role of platelets in early detection and molecular profiling of cancers.
MRC WIMM DPhil Scholar
Antonio graduated in biochemistry in Murcia, Spain in 2018 and was then awarded an Erasmus+ scholarship to join Professor Ouwehand's and Dr Mendez-Ferrer's labs in Cambridge. Here, he developed experience working with iPSCs and CRISPR-cas9 editing. He has also completed a masters degree in bioinformatics and biostatistics.
He is currently a 2nd year PhD student working on the regulation of whole genome duplication in megakarycytes.
Senior Research Assistant
Aude is a senior research assistant who recently joined us from the Higgs/Babbs Group. We are delighted to have her join, bringing her extensive experience in cell culture, molecular biology and background in erythropoiesis. She works on developing and applying bone marrow organoids to study normal and malignant haematopoiesis
PhD Student (NIH-OxCam Scheme)
Zoe is a PhD student on the NIH-OxCam Scholarship Scheme. After her 1st year in Chris Hourigan's lab working on AML MRD she has come to Oxford to work on using our bone marrow organoids platform to explore how inflammators perturbations and fibrosis in the bone marrow niche alter clonal competition and anti-tumour immunity.
YUQI SHEN, PHD
Yuqi is a talented scientist with not one but two PhDs, most recently working with Doug Higgs and Richard Gibbons. She is working on an exciting project co-supervised by Adam Mead, in collaboration with Alethiomics, our spin-out company.
ASSUNTA ADAMO, PHD
Assunta is an experienced scientist working alongside Yuqi on a project in collaboration with Alethiomics, jointly supervised by Adam Mead. She has a strong background in haematopoiesis research having completed her PhD with Connie Eaves in Birmingham.
Wellcome Trust Clinical Research Fellow
Charlotte is a haematology specialist trainee supervised by Adam Mead and co-supervised by Beth Psaila. Charlotte spent 18 months of her PhD in New York working with Elli Pappaemanuil, so is a highly skilled computational biologist as well as bench scientist and clinician.
Previously Kay Kendall Leukaemia Fund Postdoctoral Fellow (Mead & Psaila Labs). Now Senior Technician, Human Technopole Institute Italy
PREVIOUS: Lab Manager (Mead & Psaila Lab). NOW: Health and Safety Manager, MRC Weatherall Institute of Molecular Medicine
Previously: Research Assistant, Psaila Lab. Now: Scientist, Sitryx
Previously Postdoctoral Researcher (Mead & Psaila Labs). Now Group Leader, Shanghai Key Laboratory of Metabolic Remodelling and Health, Institute of Metabolism and
Integrative Biology, Fudan University and
Qizhi Insitute, Shanghai, China